Evidence map›Paper›PMID 41026742›Full record

ArticlePLoS neglected tropical diseases2025

Molecular epidemiology of panton valentine leukocidin-producing Staphylococcus aureus infections, Djibouti, 2018-2023.

Maxime Danjean, Virginie Courbin, Aurore Ho, Aurore Bousquet, Christophe Rodriguez, Hervé Jacquier, Paul-Louis Woerther

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maxime DanjeanUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0009-0009-7633-8167
Virginie CourbinDépartement de Biologie, Hôpital Bégin, HNIA (Hôpital National d'Instruction des Armées), Saint-Mandé, France.
Aurore HoDépartement de Biologie, Hôpital Bégin, HNIA (Hôpital National d'Instruction des Armées), Saint-Mandé, France.
Aurore BousquetDépartement de Biologie, Hôpital Bégin, HNIA (Hôpital National d'Instruction des Armées), Saint-Mandé, France.
Christophe RodriguezPlateforme de Génomique Genobiomics, Hôpital Henri Mondor, APHP, Créteil, France.
Hervé JacquierUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.
Paul-Louis WoertherUnité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.ORCID 0000-0002-6957-9482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Between 2018 and 2023, a genomic study was conducted in a military camp in Djibouti to investigate the molecular epidemiology of Panton-Valentine Leukocidin-producing Staphylococcus aureus. Among 43 isolates, Sequence Type 152 was predominant (72%), mainly associated with spa types t355 and t4235. Core-genome Multi-Locus Sequence Typing revealed two concurrent transmission dynamics: localized inter-human outbreaks and repeated introductions from external sources. Comparative genomics with other African Sequence Type 152 isolates showed similar levels of diversity, suggesting a widespread continental dissemination. These findings highlight the importance of genomic surveillance to better understand and control the spread of this virulent lineage in Africa.

Indexed as

Bacterial ToxinsExotoxinsLeukocidinsStaphylococcal InfectionsStaphylococcus aureusAdultDjiboutiHumansMaleMolecular EpidemiologyMultilocus Sequence TypingBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidin

Identifiers

PMID41026742
PMCPMC12483272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.